• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

3.380 -0.010 (-0.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 109,275
Open 3.380
Bid (Size) 3.310 (4,500)
Ask (Size) 3.340 (500)
Prev. Close 3.390
Today's Range 3.380 - 3.380
52wk Range 1.891 - 6.515
Shares Outstanding 287,686,199
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Narrower-Than-Expected Loss on Patent Settlement Windfall ↗
February 24, 2026
Via Chartmill
Topics Intellectual Property
These stocks are moving in today's after hours session ↗
February 24, 2026
Via Chartmill

Performance

YTD
-1.5%
-1.5%
1 Month
+11.6%
+11.6%
3 Month
-9.1%
-9.1%
6 Month
-29.1%
-29.1%
1 Year
+33.6%
+33.6%

More News

Read More
News headline image
AbCellera Reports Full Year 2025 Business Results
February 24, 2026
From AbCellera Biologics Inc.
Via Business Wire
News headline image
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
February 17, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
February 11, 2026
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
January 22, 2026
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
January 12, 2026
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera and Bruker Reach Global Settlement of Patent Litigation
December 18, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
November 10, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss ↗
November 06, 2025
Via Chartmill
News headline image
AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday? ↗
November 07, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
AbCellera Reports Q3 2025 Business Results
November 06, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗
November 06, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
October 07, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗
October 02, 2025
Via Benzinga
Topics Stocks
News headline image
Why Did AbCellera's Stock Jump Over 7% After Hours? ↗
October 02, 2025
Via Benzinga
News headline image
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
September 29, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
September 10, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
August 27, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
August 18, 2025
Via Benzinga
News headline image
AbCellera to Participate at Upcoming Investor Conferences in September
August 12, 2025
From AbCellera Biologics Inc.
Via Business Wire
News headline image
Expert Outlook: AbCellera Biologics Through The Eyes Of 4 Analysts ↗
August 08, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 08, 2025
Via Benzinga
News headline image
AbCellera Biologics (ABCL) Q2 2025 Earnings Call Transcript ↗
August 08, 2025
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is AbCellera Biologics Inc. - Common Shares publicly traded?
Yes, AbCellera Biologics Inc. - Common Shares is publicly traded.
What exchange does AbCellera Biologics Inc. - Common Shares trade on?
AbCellera Biologics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AbCellera Biologics Inc. - Common Shares?
The ticker symbol for AbCellera Biologics Inc. - Common Shares is ABCL on the Nasdaq Stock Market
What is the current price of AbCellera Biologics Inc. - Common Shares?
The current price of AbCellera Biologics Inc. - Common Shares is 3.380
When was AbCellera Biologics Inc. - Common Shares last traded?
The last trade of AbCellera Biologics Inc. - Common Shares was at 03/25/26 04:00 PM ET
What is the market capitalization of AbCellera Biologics Inc. - Common Shares?
The market capitalization of AbCellera Biologics Inc. - Common Shares is 972.38M
How many shares of AbCellera Biologics Inc. - Common Shares are outstanding?
AbCellera Biologics Inc. - Common Shares has 972M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap